WebOct 8, 2024 · The company’s pipeline includes optogenetics-based retinal gene therapies for patients with RP, Stargardt disease, and dry age-related macular degeneration. Contact: Dan Eramian Opus Biotech Communications [email protected] 425-306-8716 On October 8, 2024 / Nanoscope Press Release, Home Page 2 Comments Rami
Jeff Joseph on LinkedIn: I’m happy to share that I’m starting a new ...
WebOpus Biotech Communications offers a wide range of communications and consulting services especially designed for emerging companies that have compelling stories to tell to investors, potential partners and the media, but have limited resources. Opus Biotech principals have been leaders in the biotech revolution since its beginnings. WebMar 5, 2024 · BEDFORD, Texas, March 5, 2024 /PRNewswire/ — Researchers of Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for treatment of retinal diseases, ... Opus Biotech Communications [email protected] 404-245-0591. On March 5, ... read property management
Opus Biotech Communications Adds New Clients
WebOPUS The OPUS team is located to serve clients in key biotech and life sciences hubs across the US. Seattle: Daniel Eramian 425-306-8716 [email protected] San … OPUS Biotech Communications Blog. 5 Keys to a Deck that Delivers. February 4, … Opus Biotech Communications Adds New Clients Web and social media expert, … OPUS Biotech Communications Blog; ... OPUS has extensive experience working … OPUS Biotech has an extensive network of contacts built on decades of experience … WebSep 12, 2024 · Opus Biotech Communications Dan Eramian, 425-306-8716 [email protected] or Opus Biotech Communications Charles Craig, 404-245-0591 [email protected]. Release Summary. Web-Opus Biotech Communications provides expert public affairs, company and CEO reputation management and crisis management consulting services for biotech, pharma, agricultural … read property setdata of undefined